Canaccord Believes IDEXX Labs Can Meet Guidance

By: via Benzinga
Canaccord Genuity reiterated its Buy rating on IDEXX Laboratories, Inc. (NASDAQ: IDXX) and lifted the price target to $98 from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.